SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-059278
Filing Date
2018-09-28
Accepted
2018-09-28 09:16:06
Documents
3
Period of Report
2018-09-24
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-36082_18k.htm 8-K 29958
2 EX-99.1 a18-36082_1ex99d1.htm EX-99.1 7424
3 GRAPHIC g360821mmi001.jpg GRAPHIC 3260
  Complete submission text file 0001104659-18-059278.txt   43431
Mailing Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025
Business Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 8-K | Act: 34 | File No.: 001-37411 | Film No.: 181092625
SIC: 2834 Pharmaceutical Preparations